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Humoral immune responses are thought to be enhanced by complement-mediated 
recruitment of the CD21–CD19–CD81 coreceptor complex into the B cell antigen receptor 
(BCR) complex, which lowers the threshold of B cell activation and increases the survival 
and proliferative capacity of responding B cells. To investigate the role of the CD21–CD35 
complement receptors in the generation of B cell memory, we analyzed the response against 
viral particles derived from the bacteriophage Q
 
 
 
 in mice deficient in CD21–CD35 (Cr2
 
 
 
/
 
 
 
). 
Despite highly efficient induction of early antibody responses and germinal center (GC) 
reactions to immunization with Q
 
 
 
, Cr2
 
 
 
/
 
 
 
 mice exhibited impaired antibody persistence 
paralleled by a strongly reduced development of bone marrow plasma cells. Surprisingly, 
antigen-specific memory B cells were essentially normal in these mice. In the absence of 
CD21-mediated costimulation, Q
 
 
 
-specific post-GC B cells failed to induce the transcriptional 
regulators Blimp-1 and XBP-1 driving plasma cell differentiation, and the antiapoptotic 
protein Bcl-2, which resulted in failure to generate the precursor population of long-lived 
plasma cells residing in the bone marrow. These results suggest that complement receptors 
maintain antibody responses by delivery of differentiation and survival signals to precursors 
of bone marrow plasma cells.
 
Protective immunological memory against re-
infection with most viruses largely depends
on the induction of long-lasting antibody re-
sponses. This concept provides the basis of all
successful vaccines used to date (1). B cell
memory is characterized by increased fre-
quencies of long-lived memory B cells and el-
evated levels of specific antibodies (2). Both
memory B cells and BM antibody-secreting
cells (ASCs), which sustain long-term anti-
body production (3, 4), are thought to origi-
nate in germinal centers (GCs; 5). However,
the mechanisms underlying recruitment of
GC B cells into the memory B cell or BM
plasma cell compartment remain ill defined.
Selective accumulation of high affinity ASCs
in the BM has suggested that high antigen af-
finity of the B cell Ag receptor (BCR) favors
differentiation of GC B cells into plasma cells
(6, 7). Although a minimal threshold of signal
strength is required for differentiation into
a long-lived plasma cell, selection into the
memory B cell population appears to be less
stringent (6, 7). Additional signals have been
reported to drive these two pathways; for in-
stance CD40L, IL-4, or ligation of CD27 di-
rect differentiation of GC B cells toward a
memory phenotype (8–10) whereas commit-
ment to a plasma cell fate is promoted by IL-10
and requires IL-6 (9, 11, 12). Signals determin-
ing plasma cell fate decision are dependent
on the induction of the transcription factors
Blimp-1 and XBP-1 for formation of Ig-pro-
ducing cells (13, 14). Together these regulators
drive terminal differentiation of B cells into
ASCs, by promoting a plasma cell phenotype
and extinguishing gene expression programs
involved in proliferation and GC function (15).
Survival of B cells in GCs during the anti-
gen-driven selection process leading to high-
affinity memory B cells and plasma cells is
dependent on signaling through the CD21–
CD19 complex (16). The interaction of CD21
with complement-coated antigen appears to
provide a selective advantage to GC B cells.
Two additional mechanisms have been proposed
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by which CD21–CD35 enhances humoral immunity (17–19).
First, recruitment of the CD21–CD19–CD81 complex into
the BCR complex lowers the threshold of B cell activation.
Second, complement receptors CD21–CD35 enhance trap-
ping of antigen on follicular dendritic cells (FDCs) thereby
driving the GC reaction and maintaining B cell memory. In-
sight into the role of complement receptors in humoral re-
sponses has been gained through the study of mice with a
genetically disrupted 
 
Cr2
 
 locus, deficient for the expression
of CD21 (complement receptor 2) and CD35 (complement
receptor 1). These mice have been reported to have impaired
antibody responses and defective GC formation in response
to T cell–dependent and –independent antigens (20–22).
However, antibody responses were affected to a varying
degree dependent on the nature and amount of antigen used
in these studies. The role of CD21–CD35 in the generation of
immunological memory also remains controversial. Although
Cr2
 
 
 
/
 
 
 
 mice infected with vesicular stomatitis virus main-
tained memory antibody titers comparably to controls (23),
accelerated loss of serum antibody was reported in responses
to the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP; 24).
Furthermore, expression of CD21–CD35 was essential for
generation of memory B cells to carrier-coupled NP in the
absence but not in the presence of adjuvants (25).
To dissect the role of complement receptors in the induc-
tion of immunological B cell memory to a highly repetitive
antigen capable of efficient cross-linking of surface Ig on B
cells, virus-like particles from the RNA phage Q
 
 
 
 were used
as a model antigen. Q
 
 
 
 capsids form icosahedral particles of
 
 
 
30 nm diam (26) with a highly ordered repetitive structure,
which makes them potent B cell immunogens in the absence
of adjuvant (27, 28). Therefore, Q
 
 
 
 particles exhibit the ge-
ometry and size of a prototype virus without displaying po-
tentially complicating factors such as viral replication. Immu-
nization with Q
 
 
 
 induces an early, T cell–independent IgM
response, followed by a persistent and slowly declining T
cell–dependent IgG response (29). Q
 
 
 
 particles efficiently in-
duce GC formation, with antigen-specific GC B cells peak-
ing around day 12 and being still detectable at late stages after
immunization (29). Immunization of Cr2
 
 
 
/
 
 
 
 mice with Q
 
 
 
showed that short-term primary responses, induction of GCs
and memory B cell formation were independent of comple-
ment receptors. In contrast, maintenance of long-lasting anti-
body titers by BM plasma cells required CD21–CD35. CD21
promoted differentiation of a plasma cell precursor popula-
tion expressing the plasma cell–specific transcription factors
Blimp-1 and XBP-1 as well as the antiapoptotic protein Bcl-2.
These results suggest that engagement of complement recep-
tors on B cells by complement-coated antigen is critical for
generation of long-lived plasma cells in the BM responsible
for maintenance of memory antibody titers.
 
RESULTS
Maintenance of antibody titers is impaired in Cr2
 
 
 
/
 
 
 
 mice
 
Immunization with a single dose of virus-like particles derived
from the bacteriophage Q
 
 
 
 elicits strong, long
 
-
 
lasting IgG re-
sponses (29). To assess the role of complement receptors in the
induction and maintenance of antibody responses to this anti-
gen, Cr2
 
 
 
/
 
 
 
 and WT mice were immunized i.v. with 10 
 
 
 
g
Q
 
 
 
 and antibody titers were measured at several time points af-
ter immunization. Anti-Q
 
 
 
 IgG antibody levels were similar in
Cr2
 
 
 
/
 
 
 
 mice and WT mice early after immunization (Fig. 1 A).
However, whereas in WT mice serum anti-Q
 
 
 
 IgG antibodies
increased and reached a peak around day 21, antibody produc-
tion was not sustained in Cr2
 
 
 
/
 
 
 
 mice. After the third week af-
ter immunization, antibody titers in Cr2
 
 
 
/
 
 
 
 mice were substan-
tially reduced compared with WT littermates and exhibited
Figure 1. Maintenance of anti-Q  antibody titers and generation 
of BM ASCs are impaired in Cr2 /  mice. (A) C57BL/6 and Cr2 /  mice 
were immunized i.v. with 10  g Q  and Q -specific serum IgG titers were 
determined by ELISA. (B) Frequencies of Q -specific IgG ASCs in spleen 
and BM of Cr2 /  and WT mice were determined by ELISPOT assay. Values 
are given as the mean   SEM, with significant differences between means 
indicated by asterisks (*, P   0.01; **, P   0.05). The analysis was repeated 
twice on days 8, 21, and 100 with a similar result. 
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nearly a 12-fold reduction 9 wk after immunization. Thus,
Cr2
 
 
 
/
 
 
 
 mice generate normal short-term anti-Q
 
 
 
 responses but
fail to maintain antibody titers in the later phase of the response.
 
BM plasma cells but not memory B cells are reduced in Cr2
 
 
 
/
 
 
 
 
mice at late stages after immunization
 
Elevated levels of IgG antibodies are thought to be main-
tained by long-lived plasma cells residing in the BM (30) as
well as by memory B cells continually differentiating into
ASCs through activation by persisting antigen (31). We
therefore followed the kinetics of ASCs and memory B cells
in Cr2
 
 
 
/
 
 
 
 and WT mice (Fig. 1 B). As expected from serum
antibody levels, up to 12 d after immunization numbers of
Q
 
 
 
-specific ASCs were similar or slightly increased in spleen
and BM of Cr2
 
 
 
/
 
 
 
 mice compared with WT controls. At
later stages after immunization, the number of cells secreting
anti-Q
 
 
 
 IgG antibodies, especially those in the BM, were
reduced in Cr2
 
 
 
/
 
 
 
 mice and the frequency of Q
 
 
 
-specific
cells in the BM plasma cell pool was more than 10-fold
lower in Cr2
 
 
 
/
 
 
 
 mice than in WT controls 9 wk after im-
munization (Fig. 1 B). Therefore, generation of presumably
short-lived plasma cells in the spleen was normal in Cr2
 
 
 
/
 
 
 
mice but the formation of long-lived BM plasma cells was
strongly reduced.
To quantify Q
 
 
 
-specific memory B cells we used an an-
tigen-specific B cell detection system relying on detection of
Figure 2. Induction of memory B cells is normal in Cr2 /  mice. 
(A) Representative staining of splenocytes from naive and immunized mice 
to identify Q -specific (IgM; IgD; CD4; CD8; CD11b; Gr-1; YO-PRO-1) B220  
cells. PNA binding on Q -specific isotype-switched B cells is shown. 
(B) Frequency of Q -specific isotype-switched B cells in spleens of Cr2 /  
and WT mice. The analysis was repeated twice on days 8, 21, and 100 with 
a similar result. (C) Anti-Q  antibody levels induced in irradiated WT mice 
6 d after immunization and adoptive transfer of Q -binding (IgM; IgD; 
CD4; CD8; CD11b; Gr-1; YO-PRO-1) B220  B cells, total (IgM; IgD; CD4; 
CD8; CD11b; Gr-1; YO-PRO-1) B220  B cells, or B220 IgM IgD  B cells. 
Results are expressed as serum IgG ELISA titers per transferred cells. 
(D) Q -specific serum IgG levels in Cr2 /  and WT mice 6 mo after pri-
mary immunization and 6 d after secondary challenge with Q . (E) B cell 
responses induced in Cr2 /  and WT mice by injection of 25  g AP205. 
Frequencies of AP205-specific IgG ASCs in spleen and BM and of AP205-
specific memory B cells in spleen were determined 9 wk after immunization. 
AP205-specific serum IgG was measured 13 wk after primary immunization 
and 6 d after antigen recall. All data represent the mean   SEM, mean 
values statistically different from WT levels are indicated by asterisks 
(*, P   0.01; **, P   0.05). 
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bound Q
 
 
 
 to specific isotype-switched B cells by flow cy-
tometry (Fig. 2 A; 29). Activated and isotype-switched B
lymphocytes, defined as (IgM; IgD; CD4; CD8; CD11b;
Gr-1; YO-PRO-1)
 
 
 
B220
 
 
 
, were gated and analyzed for
Q
 
 
 
-binding on several days after immunization. Q
 
 
 
-specific
B cells were increased in Cr2
 
 
 
/
 
 
 
 mice early in the immune
response, but antigen-specific memory B cells reached simi-
lar frequencies in Cr2
 
 
 
/
 
 
 
 and WT mice 9 wk after immuni-
zation (Fig. 2 B). Therefore, generation and persistence of
Q
 
 
 
-specific memory B cells was normal in Cr2
 
 
 
/
 
 
 
 mice.
Frequencies of Q
 
 
 
-specific B cells in LNs reflected those
found in the spleen, while no Q
 
 
 
-binding memory B cells
could be detected in the BM (unpublished data). To confirm
that the Q
 
 
 
-binding (IgM; IgD; CD4; CD8; CD11b; Gr-1;
YO-PRO-1)
 
 
 
B220
 
 
 
 cells identified at late stages after im-
munization were memory B cells, we adoptively transferred
sorted cells into irradiated recipients and assessed whether
they mounted an anamnestic response. 6 d after adoptive
transfer and immunization, relative antibody titers (titer per
transferred cells) were significantly higher in recipient mice
that had received Q
 
 
 
-binding IgM
 
low
 
IgD
 
low
 
 B cells than in
mice transferred with naive IgM IgD  B cells or total iso-
type-switched B cells (Fig. 2 C). Thus, cells identified as
(IgM; IgD; CD4; CD8; CD11b; Gr-1; YO-PRO-1) B220 
binding Q  are bona fide memory cells.
Because normal frequencies of Q -specific memory B
cells were observed in Cr2 /  mice, we tested their ability
to mount an efficient recall response late after immunization.
Cr2 /  and WT mice were primed and challenged 6 mo
later with Q ; the increase in antibody titer was analyzed 6 d
after secondary immunization. Anti-Q  titers increased sub-
stantially in both strains, more than 70-fold in Cr2 /  mice
and nearly 50-fold in WT mice (Fig. 2 D), indicating that
recall responses were normal in Cr2 /  mice.
Similar results were obtained for a second virus-like
particle,  derived from the bacteriophage AP205. Cr2 / 
mice immunized with AP205 exhibited reduced mainte-
nance of antibody titers and generation of BM plasma cells
compared with controls 9 and 13 wk after immunization
(Fig. 2 E), despite normal induction of early antibody responses
(unpublished data). In contrast, as observed for Q , frequen-
cies of AP205-specific memory B cells and the capacity to
mount efficient recall responses to AP205 particles was com-
parable in Cr2 /  and WT mice (Fig. 2 E).
Thus, in the absence of complement receptors normal
antigen-specific memory B cells were induced by immuniza-
tion with virus-like particles, but complement receptors
were required for generation and/or maintenance of long-
lived BM plasma cells.
GCs are efficiently induced in Cr2 /  mice by immunization 
with Q 
As long-lived plasma cells, along with memory B cells are
generated in the GC reaction (5) we assessed the induction
of Q -specific GC B cells in Cr2 /  and WT mice. For this
purpose, isotype-switched Q -specific B cells were analyzed
for binding to the GC marker peanut agglutinin (PNA; Fig.
2 A) and the frequency of PNAhigh Q -specific B cells in
spleens of Cr2 /  and WT mice was determined at several
time points after immunization (Fig. 3 A). In both groups of
Figure 3. Immunization with Q  induces efficient GC formation in 
Cr2 /  mice. (A) Frequency of Q -specific PNAhigh B cells in spleens of 
Cr2 /  and WT mice. Isotype-switched Q -binding PNAhigh B cells were 
identified as shown in Fig. 2 A. Data are expressed as the mean   SEM, 
mean values statistically different from WT levels are indicated by asterisks 
(*, P   0.01; **, P   0.05). (B) Immunohistochemical detection of Q -
specific B cells and PNA-binding cells in serial sections of the spleen of 
Cr2 /  and WT mice 12 and 21 d after immunization. Original magnification: 
 62.5 (day 12);  75 (day 21).JEM VOL. 201, March 21, 2005 997
ARTICLE
mice, high frequencies of PNAhigh Q -specific B cells were
observed (Fig. 3 A) and similar peak frequencies of specific
GC B cells were reached. Surprisingly, Q -specific GC B
cells were induced earlier in Cr2 /  mice than in WT mice,
but reduced numbers of GC cells were observed at later
stages after immunization. The frequency of Q -specific
PNAlow B cells was comparable in the spleen of Cr2 /  and
WT mice at all time points analyzed (unpublished data).
These results were confirmed by immunohistochemistry
(Fig. 3 B). Staining of serial spleen sections for Q -specific B
cells (29) and PNA-binding revealed no significant difference
in the number and size of Q -specific GCs generated in
Cr2 /  and WT mice 12 and 21 d after immunization. Thus,
Cr2 /  mice exhibited no obvious deficiency in size or archi-
tecture of GCs induced by immunization with Q  particles.
Blimp-1, XBP-1, and Bcl-2 fail to be induced in isotype-
switched PNAlow B cells specific for Q  in Cr2 /  mice
The induction of normal numbers of GC B cells in Cr2 / 
mice by immunization with Q  suggested a role for com-
plement receptors in the differentiation process after antigen-
driven B cell expansion. Terminal differentiation of plasma
cells has been shown to require the transcription factors
Blimp-1 (13) and XBP-1 (14). We therefore analyzed the
induction of these two regulators of plasmacytic differentia-
tion in B220highIgMlowIgDlow Q -binding PNAhigh GC B cells
and in B220highIgMlowIgDlow Q  -specific B cells with a
PNAlow phenotype. Antigen-specific PNAhigh and PNAlow
B220  cells were gated as shown in Fig. 2 A and purified by
FACS from spleens of Cr2 /  and WT mice 12 d after in-
jection of Q . Blimp-1 and XBP-1 mRNA levels were de-
termined by quantitative RT-PCR. As apparent in Fig. 4 A,
Blimp-1 and XBP-1 mRNA was up-regulated 12–13-fold
in WT mice in the PNAlow but not in the PNAhigh Q -
specific B cell population. In contrast, in Cr2 /  mice sig-
nificant levels of Blimp-1 and XBP-1 failed to be induced in
PNAlow Q  -specific B cells. Expression of Blimp-1 and
XBP-1 in antigen-specific GC B cells from WT mice was
comparable to background levels found in purified T cells
(unpublished data). The spliced form of XBP-1, which has
been reported to appear late in plasma cell differentiation and
to be associated with increased Ig synthesis (32), could not
be detected in any of the samples (unpublished data).
To dissect the role of CD21–CD35 on B cells versus
FDCs in the induction of Blimp-1 and XBP-1, we analyzed
the expression of these transcription factors in Q -specific B
cells from chimeric mice having normal FDCs but Cr2 /  B
cells. For this purpose we transferred splenocytes derived
from Cr2 /  or WT mice into sublethally irradiated C57BL/
6-CD45.1 recipients. On days 8 and 12 after immunization
anti-Q  antibodies were present at comparable levels in both
groups of chimeras, but not in irradiated control mice that
Figure 4. Q -specific isotype-switched PNAlow B cells from Cr2 /  
mice exhibit reduced levels of Blimp-1, XBP-1, and Bcl-2 mRNA. 
Q -binding isotype-switched PNAhigh and PNAlow B cells, identified as 
shown in Fig. 2 A, were purified by FACS from three to four pooled spleens 
12 d after immunization. Blimp-1, XBP-1, and Bcl-2 mRNA levels were de-
termined by quantitative RT-PCR. (A) Expression of Blimp-1 and XBP-1 in 
purified cells from Cr2 /  and WT mice. (B) Blimp-1 and XBP-1 expression 
in Q -specific B cells from chimeric mice having Cr2 /  B cells and WT 
FDCs and from control chimeras. 5   107 splenocytes from Cr2 /  or 
C57BL/6 mice were adoptively transferred into sublethally irradiated 
C57BL/6-CD45.1 recipients and mRNA levels were determined in CD45.1  
B cells from immunized recipient mice. (C) Bcl-2 mRNA levels in sorted 
cells from Cr2 /  and WT mice. Expression levels are depicted in relation 
to  -actin expression. Quantitative RT-PCR of each sample was performed 
in triplicate. Results are represented as the mean   SD. One of two similar 
experiments is shown.COMPLEMENT REGULATES PLASMA CELL DIFFERENTIATION | Gatto et al. 998
had not received any B cells (unpublished data). As ob-
served for Cr2 /  mice, sorted Q -specific isotype-switched
CD45.1 B220 PNAlow B cells from chimeric mice having
Cr2 /  B cells and WT FDCs displayed strongly reduced
Blimp-1 and XBP-1 mRNA levels when compared with
cells from control chimeras (Fig. 4 B). Hence, in the absence
of stimulation through complement receptors, Q -specific
isotype-switched PNAlow B cells were unable to induce suffi-
cient levels of the key transcription factors driving plasma cell
differentiation. This indicates that the failure of Cr2 /  mice
to generate long-lived plasma cells is a B cell–intrinsic defect
and is not related to the absence of CD21–CD35 on FDCs.
The reduction of Blimp-1 and XBP-1 levels in PNAlow
Q -specific B cells from Cr2 /  mice was concomitant to a
reduced expression of the antiapoptotic protein Bcl-2 (Fig. 4
C). This observation is consistent with in vitro studies show-
ing that recruitment of the B cell coreceptor during antigen-
dependent B cell activation induced Bcl-2 expression (33).
Thus, absence of survival mechanisms regulated by Bcl-2 may
further explain the loss of BM plasma cells in Cr2 /  mice.
Q -specific isotype-switched B220highPNAlow cells are not 
secreting antibody
We next set out to characterize further the Q -specific iso-
type-switched B220highPNAlow B cell population that ex-
pressed the transcriptional regulators Blimp-1 and XBP-1 and
the antiapoptotic protein Bcl-2 that was absent in Cr2 / 
mice. As Blimp-1 and XBP-1 are expressed in plasma cells,
we assessed whether Q -specific PNAlow B cells were secret-
ing antibody and determined the phenotype of splenic plasma
cells 12 d after immunization. For detection of Q -specific
plasma cells, splenocytes were permeabilized and intracellular
binding of fluorescently labeled Q  particles to (CD4; CD8;
CD11b) B220high and B220low B cells was determined by
flow cytometry. Surface staining was blocked by preincuba-
tion with unlabeled Q . As shown in Fig. 5 A, Q -specific
plasma cells, expressing high levels of cytoplasmic antibodies,
had exclusively a B220lowPNAlow phenotype. These bright
intracellularly stained cells could only be detected after per-
meabilization, consistent with the fact that terminally differ-
entiated plasma cells down-regulate surface Ig expression.
Cells expressing Q -specific cytoplasmic antibodies were ab-
sent when B220high B cells were gated, therefore excluding
that the Blimp-1– and XBP-1–expressing PNAlow B cells,
which displayed a B220high phenotype, were terminally dif-
ferentiated plasma cells. A population of B220lowPNAlow cells
exhibiting cytoplasmic Igs specific for Q  could also be de-
tected in Cr2 /  mice. The frequency of these cells was
comparable in the spleen of Cr2 /  and WT mice (Fig. 5 B).
This is consistent with the normal ASC numbers detected on
Figure 5. B220highPNAlow B cells specific for Q  are not secreting 
antibody. (A) Splenocytes from naive and immunized (day 12) WT mice 
were permeabilized and intracellular expression of Q -specific antibodies 
was detected with Alexa 647-labeled Q . (CD4; CD8; CD11b) B220high and 
B220low cells were gated and analyzed for PNA binding. Mean percentages 
of Q -specific plasma cells are indicated. Surface staining was blocked by 
preincubation with unlabeled Q ; the specificity of the staining was con-
trolled with Alexa 647-conjugated AP205. (B) Frequency of Q -specific 
B220lowPNAlow plasma cells in spleen of Cr2 /  and WT mice on day 12 
after immunization. Values are given as the mean   SEM.JEM VOL. 201, March 21, 2005 999
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day 12 in Cr2 /  mice by ELISPOT assay, which were in
the same range as those obtained by flow cytometry.
These results suggest that the Q -binding isotype-
switched B220highPNAlow population that expresses the tran-
scription factors Blimp-1 and XBP-1 and fails to develop in
Cr2 /  mice, are antigen-experienced B cells that have left
GCs and are committed to a plasma cell fate, but have not
yet fully differentiated into ASCs.
Q -specific GC-derived BM plasma cell precursors are 
absent in Cr2 /  mice
A population of B cells representing an intermediary stage
before terminal plasma cell differentiation has been de-
scribed recently (34). These post-GC B cells, which are di-
rect precursors to plasma cells, were identified in the BM
and display a phenotype intermediate between splenic B
cells and terminally differentiated plasma cells. Such plasma
Figure 6. Q -specific isotype-switched PNAlow B cells exhibiting a 
partial plasma cell phenotype are absent in Cr2 /  mice. (A) Expression 
of CD138, VLA-4, LFA-1, and CD44 on Q -specific PNAlow and PNAhigh B cells 
from WT mice. B220  splenocytes were purified by magnetic cell sorting; 
IgMlowIgDlow B cells binding Q  and low or high levels of PNA were gated 
and analyzed for expression of the indicated surface markers. One of three 
similar experiments is shown. (B) Comparison of CD138, VLA-4, LFA-1, and 
CD44 expression on Q -specific PNAlow and PNAhigh isotype-switched 
B220  splenocytes from Cr2 /  and WT mice on day 12 after immunization. 
(C) Phenotype of Q -specific B cells in the blood of WT mice on day 12 after 
immunization. PNA-binding on Q -specific (IgM; IgD; CD4; CD8; CD11b; 
Gr-1; YO-PRO-1) B220  cells was determined. Expression of cytoplasmic Ig 
in Q -specific PNAlow B cells was assessed by analysis of binding of 
Alexa647-labeled Q  to permeabilized (CD4; CD8; CD11b) B220low cells.COMPLEMENT REGULATES PLASMA CELL DIFFERENTIATION | Gatto et al. 1000
cell precursors were shown to retain expression of the
BCR, B220, and MHCII, albeit lower levels than splenic B
cells, and to express the plasma cell marker CD138 as well as
receptors capable of interacting with BM stroma, such as
VLA-4, LFA-1, and CD44 (34). To confirm the identity of
Q -specific PNAlow Blimp-1–XBP-1–expressing B cells as
precursors of plasma cells, the expression of these surface
markers identifying post-GC plasma cell precursors was de-
termined on isotype-switched PNAlowB220high B cells bind-
ing Q  12 d after immunization. As shown in Fig. 6
A, CD138 was induced on a proportion of Q -binding
PNAlow B cells but not on specific GC B cells. The integrins
VLA-4 and LFA-1 as well as CD44 were also up-regulated
on Q -specific PNAlow B cells compared with the PNAhigh
B cell population. Therefore, cell surface markers, which
are known to be up-regulated in the differentiation process
of post-GC B cells to BM plasma cells, were induced in iso-
type-switched Q -specific PNAlow B cells. The presence of
cells with this plasma cell precursor phenotype was also de-
termined in immunized Cr2 /  mice (Fig. 6 B). Consis-
tent  with the fact that Blimp-1–XBP-1–positive isotype-
switched B cells binding Q  were absent in these mice, a
population of cells with up-regulated CD138, VLA-4, LFA-1,
and CD44 expression failed to be induced. These results in-
dicate that generation of post-GC precursors to plasma cells
requires the interaction of complement-coated antigen with
its receptors.
In support of the hypothesis that the identified popula-
tion represented plasma cell precursors destined to migrate to
the BM, Q -specific B cells identified in the blood of im-
munized mice had a B220highPNAlow phenotype and did not
express cytoplasmic Igs (Fig. 6 C). This suggests that Q -
specific precursors of plasma cells homed to the BM before
terminal differentiation, in accordance with the presence of a
plasma cell precursor population in this organ (34). How-
ever, cells with surface Ig specific for Q  could not be de-
tected in the BM at any time point. This is an indication that
upon arrival in the BM, precursors of plasma cells rapidly
lose surface Ig expression and acquire cytoplasmic Ig expres-
sion as required for antibody secretion.
Preplasma memory B cells are formed normally in Cr2 /  mice
A population of memory B cells, which originate in GCs
and can been distinguished from classical recirculating
B220  memory B cells on the basis of their B220 
CD138  phenotype, has been described previously (35,
36). These cells have a greater propensity to form plasma
cells than the B220  memory B cell subset and rapidly dif-
ferentiate into plasma cells after antigen recall (35). Nonse-
creting B220 CD138  B cells have been referred to as
preplasma memory B cells and their formation has been
shown to require Blimp-1 expression (13). Because com-
plement receptors played a role in the induction of Blimp-1,
we analyzed the generation of preplasma memory B
cells in Cr2 /  mice immunized with Q . As shown in
Fig. 7 A, a population of Q -binding (IgD; CD4; CD8;
YO-PRO-1)  cells with a B220 CD138  phenotype
could be detected in the spleen of immunized Cr2 /  and
WT mice. The frequency of these cells on days 12 and 21
was comparable in Cr2 /  and WT controls (Fig. 7 B).
Thus, generation of preplasma memory B cells was not de-
pendent on complement receptors, despite their formation
reportedly requiring Blimp-1 expression. As already men-
tioned, cells with surface Ig receptors specific for Q 
could not be detected in the BM and therefore no Q -
specific preplasma memory B cells could be identified in
this organ.
Figure 7. Preplasma memory B cells are induced normally in Cr2 /  
mice. (A) Analysis of B220 and CD138 expression on Q -binding (IgD; 
CD4; CD8; YO-PRO-1)  splenocytes to identify B220 CD138  preplasma 
memory B cells. Mean percentages of B220-CD138 , B220 CD138 , and 
CD138  cells in Cr2 /  and WT mice are indicated. (B) Frequency of Q -
specific preplasma memory B cells in spleens of Cr2 /  and WT mice 12 
and 21 d after immunization. Results are expressed as the mean   SEM.JEM VOL. 201, March 21, 2005 1001
ARTICLE
Generation of isotype-switched Q -specific PNAlow B cells is 
GC dependent
The fact that short-term anti-Q  antibody responses were
normal in Cr2 /  mice suggested that complement recep-
tors were required mainly for differentiation of GC-derived
plasma cells. Consequently, if isotype-switched PNAlow B
cells, which required complement receptors for induction
of Blimp-1 and XBP-1, are post-GC plasma cell precursors,
this population should not be induced in the absence of
GCs. To address this question we analyzed the generation
of isotype-switched B220  PNAhigh and PNAlow B cells in
TNFR1 /  mice, which lack mature FDC networks and
do not form GCs (37). As expected, on day 12 after immu-
nization, Q -specific PNAhigh GC B cells were absent in
spleens of TNFR1 /  mice (Fig. 8 A). Q -specific B cells
with a PNAlow phenotype were also more than 10-fold re-
duced, indicating that these cells are generated in GCs (Fig.
8 A). Further, lower frequencies of splenic B220lowPNAlow
cells expressing cytoplasmic Igs specific for Q  were de-
tected in TNFR1 /  mice (Fig. 8 B), suggesting that a pro-
portion of these antibody-producing cells derived from GC
B cells. Cells with this phenotype were present in normal
numbers in Cr2 /  mice (Fig. 5 B). Hence, some of the
plasma cells in the spleen of Cr2 /  mice did arise from the
GC reaction and are likely to represent splenic short-lived
plasma cells.
The lack of GC formation resulted in reduced anti-Q 
IgG antibody levels in TNFR1 /  mice compared with WT
controls (Fig. 8 C). However, early antibody production was
normal, similarly to what was observed in Cr2 /  mice. Not
affected by the absence of GCs was also the ability of
TNFR1 /  mice to mount efficient recall responses. These
results are consistent with earlier studies showing normal in-
duction of memory B cells and reduced persistence of anti-
body titers in TNFR1 /  mice after immunization with ve-
sicular stomatitis virus (38).
The fact that in the absence of GCs the course of the
anti-Q  antibody response was remarkably similar to the
response observed in Cr2 /  mice, suggests that Cr2 / 
mice have a defect in the generation of GC-derived plasma
Figure 8. Isotype-switched Q -specific PNAlow B cells are reduced 
in the absence of GC formation. (A) Frequency of total, PNAhigh and 
PNAlow Q -binding isotype-switched B220  cells in spleens of TNFR1 /  
and WT mice 12 d after immunization. (B) Frequency of splenic B220low 
plasma cells with cytoplasmic Ig specific for Q  in immunized TNFR1 /  
and WT mice. (C) Levels of anti-Q  serum IgG antibodies induced in 
TNFR1 /  and WT mice by immunization with Q . Mice were boosted on 
day 55 after primary immunization for analysis of recall responses. All 
data represent the mean   SEM, mean values statistically different from 
WT levels are indicated by asterisks (*, P   0.01; **, P   0.05).
Figure 9. Short-term trapping of Q  particles is efficient but long-
term antigen retention is reduced in Cr2 /  mice. Histological staining 
of Q  antigen on spleen sections from WT and Cr2 /  mice on days 0, 12, 
and 21 after immunization with 100  g Q . Original magnification:  50 
(B6, day 0);  75 (Cr2 / , day 0);  69 (day 12);  82.5 (day 21).COMPLEMENT REGULATES PLASMA CELL DIFFERENTIATION | Gatto et al. 1002
cells. The reduction of Q -specific isotype-switched PNAlow
B cells in the absence of GCs provides further evidence
that this population, which requires complement recep-
tors for up-regulation of Blimp-1 and XBP-1, originates
in GCs.
Short-term antigen trapping is efficient but long-term 
antigen persistence is reduced in Cr2 /  mice
Complement receptors together with Fc  receptors mediate
antigen trapping on FDCs thereby sustaining humoral immu-
nity. Therefore, we analyzed antigen retention in the spleen
of Cr2 /  and WT mice 12 and 21 d after injection of 100
 g Q ; at these time points, deposits of Q  particles are
found exclusively in B cell follicles (Fig. 9). Histological stain-
ing for Q  antigen showed that antigen was efficiently
trapped in the spleen of Cr2 /  mice at day 12 (Fig. 9); note
that at this time point Blimp-1 and XBP-1 expression in the
PNAlow B cell population was already dramatically different
between Cr2 /  and WT mice. However, 3 wk after immu-
nization, deposits of Q  antigen were reduced in Cr2 / 
mice compared with controls (Fig. 9). This suggests that
binding of Ag-IgG complexes to Fc  receptors was sufficient
to ensure short-term antigen trapping but complement recep-
tors were required for long-term antigen persistence. The
reduced time span of Q  trapping in Cr2 /  mice may be
responsible for the faster decline of GC reactions in these mice.
DISCUSSION
Complement receptors provide an important link between
innate and acquired immunity and their role in the induc-
tion of humoral immune responses has been clearly demon-
strated (20, 22, 39). In this study, we dissected the role of
CD21–CD35 complement receptors in the induction of dif-
ferent effectors of humoral memory. We showed that in re-
sponse to repetitive antigens, such as virus-like particles de-
rived from bacteriophages Q  and AP205, generation of
antigen-specific memory B cells was normal, but differentia-
tion of GC B cells into long-lived plasma cells residing in the
BM was substantially reduced. As a consequence, Cr2 / 
mice were unable to maintain persistent antibody titers, a
hallmark of protective, long-lasting humoral immunity.
Considering that both memory B cells and BM plasma cells
are end products of the GC reaction, it was surprising that
only generation of BM plasma cells was affected by absence
of complement receptors. Distinct differentiation pathways
have been postulated for the selection of these two compart-
ments in GCs. Whereas high affinity for antigen is required
for commitment to a plasma cell fate, the memory B cell
population appears to be more heterogeneous with respect
to affinity and its survival in GCs relies on antigen-depen-
dent signals preventing apoptosis (6, 7). Our results suggest
that not only does coligation of the CD21–CD19–CD81
coreceptor and the BCR by complement-coated antigen de-
crease the affinity threshold needed for B cell activation (40),
but it also increases the avidity of the interaction of B cells
with antigen as required for promoting differentiation of GC
B cells into BM plasma cells. In the absence of CD21, the
threshold of signal strength required for differentiation into
long-lived plasma cells may not be reached by most GC B
cells, but signaling may still be sufficient for differentiation
and survival of memory B cells. We therefore speculate that
those few BM plasma cells that develop in Cr2 /  mice (Fig.
1 B) are clones with high affinity BCR, which compensates
for the lack of CD21. This would be consistent with in-
creased affinity maturation in Cr2 /  mice, which has been
reported but is subject to debate (24, 25). Short-term anti-
body responses induced by immunization with Q  were
normal in Cr2 /  mice. This indicates that different mecha-
nisms underlie regulation of short-lived, non-GC–derived
plasma cells participating to the early phase of the antibody
response and BM plasma cells responsible for long-term
maintenance of memory titers.
The degree of antigen organization is crucial to the acti-
vation of B cells (41) as well as to the requirement for co-
stimulatory molecules (42). Highly repetitive antigens such
as viral particles are capable of efficient cross-linking of
BCRs, which induces potent antibody responses even in the
absence of T cells (43) or CD21–CD35 (28). Q  capsids dis-
play a highly ordered structure comparable to that of viruses,
conferring on them the ability to efficiently cross-link sur-
face Ig on B cells. This may explain why antibody responses
and GC reactions were efficiently induced by immunization
with Q  particles in Cr2 /  mice and is consistent with pre-
vious reports of normal antibody responses to vesicular sto-
matitis virus (23) and influenza virus (44) in these mice. In
contrast, efficient antibody responses to other experimental
antigens lacking the structural feature repetitiveness seem to
be more dependent on CD21 (21, 22, 24). However, al-
though antigen repetitiveness was able to compensate for the
absence of CD21 to some extent, generation of persistent se-
rum antibody was not achieved by immunization with Q .
Similarly, an increase of antigen load or administration of an-
tigen in inflammatory adjuvants has been shown to mitigate
the defects in humoral responses of Cr2 /  mice (20, 24, 25);
nevertheless antibody persistence was impaired even with
optimal antigen doses in adjuvant (24).
Reduction of Q -specific BM plasma cells in Cr2 / 
mice correlated with a failure to induce Blimp-1 and XBP-1
expression in post-GC B cells, from which long-lived BM
ASCs are thought to arise (45). This observation suggests
that complement receptors are essential for Blimp-1–XBP-1–
mediated induction of plasmacytic differentiation in GCs.
Blimp-1 has been described to be expressed in a small subset
of GC B cells (46, 47). Owing to their partial plasma pheno-
type these Blimp-1  GC cells were assumed to be commit-
ted to exit GCs and to differentiate into plasma cells. In
contrast to previous reports we did not detect Blimp-1
expression in Q -specific GC B cells, but transcription of
Blimp-1 was present in isotype-switched B cells with a
PNAlow phenotype and surface Ig specific for Q . Consis-
tent with the expression of transcriptional regulators driving
plasma cell differentiation, these cells displayed a partialJEM VOL. 201, March 21, 2005 1003
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plasma cell phenotype, characterized by the up-regulation of
CD138, VLA-4, LFA-1, and CD44. A corresponding popu-
lation of Q -specific B cells with this phenotype was absent
in Cr2 /  mice. This is in accordance with a failure of post-
GC to induce Blimp-1 and XBP-1 in the absence of com-
plement-mediated stimulation. Despite expression of Blimp-1
and XBP-1, Q -specific PNAlowB220high B cells did not
stain for intracellular Ig, indicating that BM plasma cell pre-
cursors may leave the spleen before they secrete antibodies.
A clear role for complement receptors on FDCs in the
maintenance of B cell memory has been demonstrated in
chimeric mice with Cr2 /  FDC stroma and normal B cells
(48). FDCs are thought to mediate long-term antigen reten-
tion, which may continually stimulate differentiation of
memory B cell into ASCs (31, 49). The reduced persistence
of Q  particles on FDCs observed in Cr2 /  mice in this
study, confirmed the role of complement receptors in long-
term antigen retention. However, the presence of substantial
Q  depots in Cr2 /  mice on day 12 suggests that Ag–IgG
complexes on FDCs were efficiently trapped through Fc  re-
ceptors for short periods after immunization. Despite normal
antigen trapping at this time point, Cr2 /  mice failed to in-
duce Blimp-1, XBP-1, and Bcl-2 expression and to up-reg-
ulate surface molecules characteristic of plasma cell precur-
sors. This indicates that reduced antigen retention was not
responsible for the observed phenotype and is in agreement
with previous studies reporting a direct role for CD21–
CD35 on B cells for induction of long-lasting antibody re-
sponses (50, 51). Nevertheless, a lack of complement recep-
tors on FDCs and consequent reduced long-term antigen
trapping may contribute to the inability of Cr2 /  mice to
maintain long-term ASCs and is compatible with our obser-
vation that GC reactions decayed more rapidly.
In conclusion, our results suggest that induction of long-
lasting antibody production, which is mediated primarily by
BM plasma cells, requires more than BCR signaling, even
with antigens that are capable of efficient BCR cross-link-
ing, such as viral particles. A complement-mediated signal,
revealing the activation of the innate immune system, is es-
sential. This allows focusing long-term antibody production
on pathogens and keeps the induction of plasma cells capable
of secreting specific IgG antibodies over extended periods of
time under tight control of both the adaptive and the innate
immune system.
MATERIALS AND METHODS
Mice and antigens. C57BL/6 mice (Harlan), Cr2 /  mice (20),
TNFR1 /  mice (52), and C57BL/6–CD45.1 mice were immunized i.v.
with 10 or 100  g Q  or 25  g AP205. Animal experiments were con-
ducted in accordance with protocols approved by the Swiss Federal Veteri-
nary Office.
Q  capsids were expressed using the vector pQ 10 and purified as de-
scribed previously (53). AP205 coat protein (54) was cloned into the pQb10
vector (26) and expressed and purified similarly as Q .
ELISA. ELISAs were performed as described previously (29). Titers repre-
sent log2 dilutions of 40-fold prediluted sera at half maximal OD.
ELISPOT assay. Q /AP205-specific ASC frequencies were determined
as described previously (55). In brief, 24-well plates were coated with 10
 g/ml Q  or AP205. Spleen or BM cells were added in MEM containing
2% FCS and incubated for 5 h at 37 C. Cells were washed off and plates
were incubated successively with goat anti–mouse IgG (EY Labs) and alka-
line phosphatase-conjugated donkey anti–goat IgG antibodies (Jackson Im-
munoResearch Laboratories) before development of alkaline phosphatase
color reactions.
Flow cytometry. Detection of B cells expressing Q -specific surface Ig
was performed by incubation with Q , followed by a polyclonal rabbit anti-
Q  serum (produced by RCC Ltd.) and Cy5-conjugated donkey anti–rabbit
IgG serum (Jackson ImmunoResearch Laboratories). AP205-specific B cells
were identified similarly, using a polyclonal rabbit anti-AP205 serum (gener-
ated in the laboratory of Dr. P. Pumpens, University of Latvia, Riga, Latvia).
Isotype-switched B cells were detected with a mixture of FITC-conju-
gated antibodies (anti-IgD, 11-26c.2a; goat anti-IgM serum; Jackson Immu-
noResearch Laboratories; anti-CD4, GK1.5; anti-CD8, 53–6.7; anti-CD11b,
M1/70; anti-Gr-1, RB6-8C5), and PE-TxR–conjugated anti-B220 (RA3-
6B2). Biotinylated PNA (Vector Laboratories) and streptavidin-PE were
used to assess PNA-binding. Preplasma memory B cells were detected with
biotinylated anti-CD138 (281–2), streptavidin-Tricolor, PE-conjugated
anti-B220 (RA3-6B2), and FITC-conjugated antibodies to IgD (11-26c.2a),
CD4 (GK1.5), and CD8 (53–6.7). Dead cells were excluded by staining
with 0.005  g/ml YO-PRO-1 (Molecular Probes).
To characterize PNAlow Q -specific B cells, B220  splenocytes, puri-
fied by magnetic cell sorting with B220 MicroBeads (Miltenyi Biotec),
were stained with biotinylated antibodies (anti-CD138, 281–2; anti-
CD11a, M17/4; anti-CD49d, R1-2; and anti-CD44, IM7) followed by
streptavidin-Tricolor (Caltag) and PE-conjugated goat anti–mouse IgM
F(ab )2 (Southern Biotechnology Associates, Inc.), PE-conjugated rat anti–
mouse IgD (11–26; eBioscience), FITC-conjugated PNA.
Q -specific plasma cells were detected by incubation with unlabeled
Q , to block binding to surface IgG, and biotinylated PNA followed by
streptavidin-PE, PE-TxR–conjugated anti-B220 (RA3-6B2), and FITC-
conjugated antibodies to CD4 (GK1.5), CD8 (53–6.7), and CD11b (M1/70).
After permeabilization, cells were incubated at room temperature with Q 
particles labeled with the fluorochrome Alexa 647, using the Alexa Fluor
647 Protein Labeling Kit (Molecular Probes).
Fc-receptors were blocked with anti–mouse CD16/32 (2.4G2). Anti-
bodies were purchased from BD Biosciences unless otherwise specified.
Adoptive transfer experiments. 5   107 splenocytes from naive Cr2 / 
and C57BL/6 mice were transferred with 10  g Q  into sublethally irradi-
ated (450 rads) C57BL/6-CD45.1–recipient mice. Irradiated control mice
were given antigen but no cells.
For adoptive transfer of memory B cells, Q -binding IgMlowIgDlow and
total IgMlowIgDlow splenocytes were purified by FACS from C57BL/6 mice
immunized 6 wk previously. Control naive B cells (IgM IgD ) were sorted
from unimmunized mice. Single cell suspensions of 104 Q -binding IgM-
lowIgDlow, 105 IgMlowIgDlow, or 105 IgM IgD  B cells were injected to-
gether with 107 purified CD4  cells into sublethally irradiated recipients,
which were immunized with 10  g Q .
Immunohistochemistry. Freshly removed organs were snap frozen in
liquid nitrogen. Tissue sections of 5  m thickness were cut in a cryostat and
fixed with acetone. For detection of Q  antigen, sections were incubated
with rabbit anti-Q  serum (RCC), followed by biotinylated sheep anti–
rabbit Igs (The Binding Site) and alkaline phosphatase–labeled streptavidin
(Roche). Alkaline phosphatase was visualized using the Vector Blue sub-
strate (Vector Laboratories). Sections were counterstained with Vector Nu-
clear Fast Red (Vector Laboratories).
For detection of Q -specific B cells, spleen sections were incubated
with Q  and bound particles were detected with a polyclonal anti-Q  se-
rum as described previously (29). PNA-binding cells were stained with bio-COMPLEMENT REGULATES PLASMA CELL DIFFERENTIATION | Gatto et al. 1004
tinylated PNA (Vector Laboratories) followed by avidin–biotin–peroxidase
complexes (DAKO) before alkaline phosphatase was visualized.
Quantitative RT-PCR. 5   104–105 specific B cells were sorted into
TRI Reagent (Molecular Research Center) and total RNA was extracted
according to the manufacturer’s instructions. First strand cDNA was synthe-
sized using random nonamer primers and SuperScript II reverse tran-
scriptase (Invitrogen). Quantitative real-time PCR was performed on an
iCycler Thermal Cycler (Bio-Rad Laboratories) using the following primers
for amplification (sense primer is given first): for Blimp-1 ATGGAG-
GACGCTGATATGAC and GATGCCTCGGCTTGAAC; for XBP-1
CGTAGACGTTTCCTGGCTATG and GGACCGGGTACCATGAG;
for Bcl-2 TCGTGACTTCGCAGAGATG and AACTCAAAGAAGG-
CCACAATC; for  -actin TCACCATGGATGATGATATCGC and
TGAAGGTCTCAAACATGATCTGG. Quantification of  -actin cDNA
was performed for each sample to allow for normalization between samples.
Dissociation curve analysis was performed to verify the presence of a single
PCR product. Quantification of the transcripts was determined with the
iCycler iQ Optical System Software (Bio-Rad Laboratories) using the com-
parative threshold cycle method.
Statistical analysis. Levels of statistical significance between means were
determined using a Student’s t test.
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